Fig. 7From: Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasisARNP suppresses pulmonary metastases secondary to bone metastasis. (A) Photographic image of lung secondary metastases from different treatment groups. (B) Lung metastatic nodule numbers in the different treatment groups. (C) Lung H&E staining of different treatment groups. All data are presented as the mean ± SD (n = 6). *p < 0.05, **p < 0.01Back to article page